Bronchoscopy and airway management in patients with mucopolysaccharidoses (MPS)

Pediatric Pulmonology

Volumn 48, Issue 6, 2013, Pages 601-607

  Muhlebach, Marianne S ^a   Shaffer, Christopher B ^a   Georges, Linda ^a   Abode, Kathy ^a   Muenzer, Joseph ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

airway; anesthesia; Bronchoscopy; intubation; mucopolysaccharidoses

Indexed keywords

GLYCOSAMINOGLYCAN;

ADENOID HYPERTROPHY; ARTICLE; BRONCHOSCOPY; CHILD; CLINICAL ARTICLE; HUMAN; INFANT; LARYNGOMALACIA; MEDICAL RECORD REVIEW; MUCOPOLYSACCHARIDOSIS; NASOTRACHEAL INTUBATION; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATION CONTROL; RETROSPECTIVE STUDY; SCHOOL CHILD; TRACHEOBRONCHOMALACIA; TRACHEOSTOMY;

ADOLESCENT; AIRWAY MANAGEMENT; ALGORITHMS; ANESTHESIA; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; MALE; MUCOPOLYSACCHARIDOSES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84878312676     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22629     Document Type: Article

References (25)

1. Muenzer J,. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr 2004; 144: S27-S34. (Pubitemid 38591272)
2. Mendelsohn NJ, Harmatz P, Bodamer O, Burton BK, Giugliani R, Jones SA, Lampe C, Malm G, Steiner RD, Parini R,. Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med 2010; 12: 816-822.
3. Chan YL, Lin SP, Man TT, Cheng CR,. Clinical experience in anesthetic management for children with mucopolysaccharidoses: report of ten cases. Acta Paediatr Taiwan 2001; 42: 306-308.
4. Chen YL,., Wu KH,. Airway management of patients with craniofacial abnormalities: 10-year experience at a teaching hospital in Taiwan. J Chin Med Assoc 2009; 72: 468-470.
5. Belani KG, Krivit W, Carpenter BL, Braunlin E, Buckley JJ, Liao JC, Floyd T, Leonard AS, Summers CG, Levine S, et al. Children with mucopolysaccharidosis: perioperative care, morbidity, mortality, and new findings. J Pediatr Surg 1993; 28: 403-408, discussion 408-410.
6. John A, Fagondes S, Schwartz I, Azevedo AC, Barrios P, Dalcin P, Menna-Barreto S, Giugliani R,. Sleep abnormalities in untreated patients with mucopolysaccharidosis type VI. Am J Med Genet 2011; 155A: 1546-1551.
7. Nashed A, Al-Saleh S, Gibbons J, MacLusky I, MacFarlane J, Riekstins A, Clarke J, Narang I,. Sleep-related breathing in children with mucopolysaccharidosis. J Inherit Metab Dis 2009; 32: 544-550.
8. Roland PS, Rosenfeld RM, Brooks LJ, Friedman NR, Jones J, Kim TW, Kuhar S, Mitchell RB, Seidman MD, Sheldon SH, et al. Clinical practice guideline: polysomnography for sleep-disordered breathing prior to tonsillectomy in children. Otolaryngol Head Neck Surg 2011; 145: S1-S15.
9. Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, et al. Multidisciplinary management of Hunter syndrome. Pediatrics 2009; 124: e1228-e1239.
10. Muenzer J, Wraith JE, Clarke LA,. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009; 123: 19-29.
11. Wold SM, Derkay CS, Darrow DH, Proud V,. Role of the pediatric otolaryngologist in diagnosis and management of children with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol 2010; 74: 27-31.
12. Muhlebach MS, Wooten W, Muenzer J,. Respiratory manifestations in mucopolysaccharidoses. Paediatr Respir Rev 2011; 12: 133-138.
13. Kamin W,. Diagnosis and management of respiratory involvement in Hunter syndrome. Acta Paediatr Suppl 2008; 97: 57-60. (Pubitemid 351421293)
14. Semenza GL, Pyeritz RE,. Respiratory complications of mucopolysaccharide storage disorders. Medicine (Baltimore) 1988; 67: 209-219.
15. Morehead JM, Parsons DS,. Tracheobronchomalacia in Hunter's syndrome. Int J Pediatr Otorhinolaryngol 1993; 26: 255-261. (Pubitemid 23146917)
16. Williamson JP, James AL, Phillips MJ, Sampson DD, Hillman DR, Eastwood PR,. Quantifying tracheobronchial tree dimensions: methods, limitations and emerging techniques. Eur Respir J 2009; 34: 42-55.
17. Ingelmo PM, Parini R, Grimaldi M, Mauri F, Romagnoli M, Tagliabue G, Somaini M, Sahillioglu E, Frawley G,. Multidetector computed tomography (MDCT) for preoperative airway assessment in children with mucopolysaccharidoses. Minerva Anestesiol 2011; 77: 774-780.
18. Leboulanger N, Louis B, Vialle R, Heron B, Fauroux B,. Analysis of the upper airway by the acoustic reflection method in children with mucopolysaccharidosis. Pediatr Pulmonol 2011; 46: 587-594.
19. Walker RW, Dearlove OR,. Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care 1997; 25: 197-198.
20. Kempthorne PM, Brown TC,. Anaesthesia and the mucopolysaccharidoses: a survey of techniques and problems. Anaesth Intensive Care 1983; 11: 203-207.
21. Moores C, Rogers JG, McKenzie IM, Brown TC,. Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care 1996; 24: 459-463. (Pubitemid 126449239)
22. Link B, de Camargo Pinto LL, Giugliani R, Wraith JE, Guffon N, Eich E, Beck M,. Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey. Orthop Rev (Pavia) 2010; 2: e16.
23. Muenzer J, Beck M, Eng CM, Giugliani R, Harmatz P, Martin R, Ramaswami U, Vellodi A, Wraith JE, Cleary M, et al. Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome. Genet Med 2011; 13: 95-101.
24. Alcalde-Martin C, Muro-Tudelilla JM, Cancho-Candela R, Gutierrez-Solana LG, Pintos-Morell G, Marti-Herrero M, Munguira-Aguado P, Galan-Gomez E,. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS). Eur J Med Genet 2010; 53: 371-377.
25. Sifuentes M, Doroshow R, Hoft R, Mason G, Walot I, Diament M, Okazaki S, Huff K, Cox GF, Swiedler SJ, et al. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 2007; 90: 171-180. (Pubitemid 46108607)